Tyme Technologies Inc (TYME)

NASDAQ
1.0400
+0.0100(+0.97%)
After Hours
1.0300
-0.0100(-0.9615%)
- Real-time Data
  • Volume:
    718,397
  • Bid/Ask:
    1.0300/1.0400
  • Day's Range:
    1.0100 - 1.0500
  • Type:Equity
  • Market:United States
  • ISIN:US90238J1034
  • CUSIP:00090238J103

TYME Overview

Prev. Close
1.03
Day's Range
1.01-1.05
Revenue
-
Open
1.02
52 wk Range
0.85-4.97
EPS
-0.18
Volume
718,397
Market Cap
179.1M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
6,786,068
P/E Ratio
-
Beta
0.92
1-Year Change
2.97%
Shares Outstanding
172,206,894
Next Earnings Date
Nov 10, 2021
What is your sentiment on Tyme Technologies Inc?
or
Market is currently closed. Voting is open during market hours.

Tyme Technologies Inc News

Tyme Technologies Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellNeutralStrong SellStrong Sell
Technical IndicatorsSellNeutralStrong BuyStrong SellStrong Sell
SummarySellNeutralBuyStrong SellStrong Sell

Tyme Technologies Inc Company Profile

Tyme Technologies Inc Company Profile

Employees
17

Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead candidate is the SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, lung, breast, prostate, sarcoma, and lymphoma. The company also offers TYME-19, an oral synthetically produced member of the bile acid family, which is in preclinical stage for the treatment of COVID-19 and disease variants; and TYME-18, a CMBT compound that is in preclinical stage for the treatment of inoperable tumors. It has research collaborations with Mayo Clinic to perform in-depth analysis of pancreatic cancer cell gene expression, epigenetic, and metabolism changes from SM-88 treatment; NYU School of Medicine to examine multiple aspects of SM-88 mechanisms; and a research investigator at Georgetown University to examine the effects of SM-88 in breast cancer. The company was formerly known as Global Group Enterprises Corp. The company was incorporated in 2011 and is headquartered in Bedminster, New Jersey.

Read More
  • sudhakars
    0
    • new CFOmerger with Swiss multinational ??
      0
      • Nice consolidation around 1.5 and it seems now is starting to show a bullish pattern, so it may be a good time to buy now
        2
        • buy now the ascent has begun; I also recommend txmd and jagxscience sector will be green for a long time
          1
          • Any recent news? They had several tests near the FDA approval but nothing has been released yet right?
            0
            • true about the covid treatment... so until they get success/approval for any of the cancer treatments like SM-88 then we may not see a rebound...
              0
            • when is the date or any road map of sm88?
              0
            • In the Tyme company page they have a picture whre they say they are in Phase III... that it seems to be the last phase. Not sure what does this represent in timelines.... https://www.tymeinc.com/our-science/pipeline/default.aspx
              0
          • Looks like EPS will hit expectations in June of -.06 per share. They are still burning through capital and burned all the offering $ at $2:50. They are going to need a breakthrough or approval very soon.
            0
            • Dump this junk buy crypto instead
              1
              • He lllyMu, geHb7u JIlO69lT TullluHy
                0
            • We are betting on a company that needs FDA approval and that doesn't happen over night!  Hang tight until next quarter and buy on the drawbacks...
              0
              • how long this basura is gonna go down
                0
                • Oops,...
                  2
                  • going to be a rough day today - If you're long, you only lose if you sell your shares and it'll recover
                    0
                    • don't worry, before up it will sideways
                      0
                      • buy now, probably news on trials this week  !!
                        3
                        • 🚀🥂
                          0
                          • 2.35 Support held well, sideways till the upside
                            0
                            • buy now !! news on friday
                              6
                              • Post your source
                                0
                              • Ryan Brown ms stock
                                2
                            • Going slow zzzzz is it worth to wait?
                              0
                              • logic not wsb
                                0
                                • 20k shares
                                  0
                                  • NOK is ready to the noon . You guys shoulf research it
                                    6
                                    • Nok trash
                                      0
                                  • Long weekend market dump, nothing to worry about, buy the dips, lower your average
                                    0
                                    • ******for volume... not sure what you think is going to happen here..
                                      0
                                      • 3.8 today
                                        1
                                        • Stay calm. Igor no have money for a chewing gum either.
                                          0
                                        • Sorin CostacheI have small position
                                          0
                                        • I was kidding, man. Everyone buys as much as they can and as much as they want.
                                          0
                                      • Gambling or longterm prospect?
                                        0
                                        • buy now  tyme on reddit !!
                                          3
                                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.